Skip to main content

Closed

SER: Serina Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-100.0% / yr

Operating margin-18803.1%

ROIC-116.6%

Financially safe

Stretched

Debt / equity0.18×

Interest coverage-1018.5×

Current ratio4.18×

Serina Therapeutics, Inc.

SERNew York Stock Exchange Arca·USD·Closed

Serina Therapeutics, Inc.

SERNew York Stock Exchange Arca·USD·Closed

$2.14

+3.88%

$2.14

+$0.08 (3.88%)

52W Range

14thpctl

Volume

0.48×avg

Mkt Cap

23.18MUSD

P/E

-1.0TTM

Div Yield

–ann

52W Range

14thpctl

Volume

0.48×avg

Market Cap

23.18MUSD

P/E Ratio

-1.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings